Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children

T. Nolan, J. Mcvernon, Peter Richmond, G.F. Hartel, J. Bennet, R.L. Basser

    Research output: Contribution to journalArticle

    29 Citations (Scopus)


    Few prospective studies of inactivated split virion influenza vaccine have been conducted in infants and children. Our objective was to evaluate the safety, reactogenicity and immunogenicity of a thimerosal-free inactivated influenza vaccine (Fluvax®; CSL Limited, Parkville, Australia) in children aged 6 months to
    Original languageEnglish
    Pages (from-to)315-325
    JournalInfluenza and Other Respiratory Viruses
    Issue number6
    Publication statusPublished - 2009


    Cite this